Pulse Biosciences, Inc.
PLSE
Peringkat dalam Saham
#4267
Pulse Biosciences, Inc. is an innovative firm specializing in bioelectric... Pulse Biosciences, Inc. is an innovative firm specializing in bioelectric medicine. Their primary offering is the CellFX System, a sophisticated, console-based platform that is precisely controlled via software. This system utilizes its proprietary Nano-Pulse Stimulation technology to deliver extremely brief, nanosecond-duration electrical pulses. This advanced method is designed to selectively eliminate target cells without thermal damage, effectively safeguarding adjacent non-cellular tissue. The CellFX System is applied in the treatment of various medical conditions. The company, originally incorporated in 2014 as Electroblate, Inc., officially became Pulse Biosciences, Inc. in December 2015. Its corporate headquarters are situated in Hayward, California.
Harga Saham
$51.39
Terakhir disinkronkan: 2026-10-21
Kapitalisasi Pasar
$3.67B
Perubahan (1 hari)
1.09%
Perubahan (1 tahun)
197.94%
Negara
US
Perdagangan Pulse Biosciences, Inc. (PLSE)
Kategori
Healthcare
Riwayat dividen untuk Pulse Biosciences, Inc. (PLSE)
Saham Pulse Biosciences, Inc. (simbol: PLSE) telah membayar total 0 dividen.
Total semua dividen (disesuaikan dengan stock split): 0.00
Imbal hasil dividen (TTM): 0
Total semua dividen (disesuaikan dengan stock split): 0.00
Imbal hasil dividen (TTM): 0
Pembayaran dividen untuk Pulse Biosciences, Inc. (PLSE) dari 2026 hingga 2026
Pembayaran dividen tahunan
| Tahun | Dividen (disesuaikan dengan stock split) | Mengubah |
|---|---|---|
| Tidak cukup data untuk tanggal yang disediakan. | ||
Daftar semua pembayaran dividen
| Tahun | Dividen | Mengubah |
|---|---|---|
| Tidak cukup data untuk tanggal yang disediakan. | ||
Pembayaran dividen untuk perusahaan sejenis atau pesaing
| Perusahaan | Jumlah pembayaran dividen | Negara |
|---|---|---|
| 0.00% |
US
|
|
| 27.00% |
FR
|
|
| 0.00% |
JP
|
|
| 175.00% |
US
|
|
| 0.00% |
CH
|
